MPM Oncology Innovations Fund LP is a venture capital fund based in Cambridge, Massachusetts. According to its most recent Form D, filed Feb 26, 2020, it has sold $98,879,004 of interests to 36 investors since its first sale in Jul 2018. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include MPM Oncology Innovations Fund GP LLC; Luke Evnin; Ansbert Gadicke.
- Total raised
- $98,879,004Cumulative sales reported on Form D
- Investors
- 36
- First sale
- Jul 12, 2018
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- MPM Oncology Innovations Fund GP LLC; Luke Evnin; Ansbert Gadicke
- Latest Form D
- Feb 26, 2020
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Feb 26, 2020 | Form D/A (amendment) | $98,879,004 | 36 | SEC.gov ↗ |
| Jul 1, 2019 | Form D/A (amendment) | $52,650,002 | 31 | SEC.gov ↗ |
| Jun 29, 2018 | Form D | $0 | 0 | SEC.gov ↗ |
3 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jun 29, 2018. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about MPM Oncology Innovations Fund LP
What is the minimum investment for MPM Oncology Innovations Fund LP?
MPM Oncology Innovations Fund LP's latest Form D, filed Feb 26, 2020, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in MPM Oncology Innovations Fund LP?
MPM Oncology Innovations Fund LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has MPM Oncology Innovations Fund LP raised?
MPM Oncology Innovations Fund LP reports $98,879,004 sold from 36 investors on its Form D filed Feb 26, 2020. This is cumulative sales since the offering began, not current assets or performance.
Where is MPM Oncology Innovations Fund LP based?
MPM Oncology Innovations Fund LP is based in Cambridge, Massachusetts.
When did MPM Oncology Innovations Fund LP launch?
MPM Oncology Innovations Fund LP reports its first sale in Jul 2018.
Size compared with every venture capital fund
Raised more than 94% of the 533 venture capital funds based in Massachusetts, and more than 98% of all 14,877 that report sales.